article thumbnail

Anti-Abortion Advocacy Groups’ Challenge to FDA-Approved Abortion Pill May Have Far-Reaching Consequences

Health Law Advisor

Food and Drug Administration (“FDA”) to withdraw approval of Mifepristone, an FDA-approved drug used to end pregnancies in the first trimester. [1] The lawsuit has sparked concern by both industry and the FDA. abortions, according to the Guttmacher Institute. [2] abortions, according to the Guttmacher Institute. [2]

FDA 59
article thumbnail

How Facial Blood Flow Patterns Can Usher a New Era of Health Vital Monitoring

HIT Consultant

Keith Thompson, Chief Medical Officer of NuraLogix Those of us old enough to recall the 1960s TV series “Star Trek” were fascinated by Dr. McCoy when he would simply point a scanner at his patients and analyze their condition. Once cleared by the FDA, these medical devices will be Class 2 software as medical device technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – July/August

SQA

Health Canada. Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. The counterfeit devices were sold online by a distributor named Healthful Plus without the required license to import, distribute, or sell medical devices in Canada.

article thumbnail

Health Provider News

Hall Render

Vincent and Morehouse School of Medicine of Atlanta to launch partnership Fayetteville nonprofit to offer state’s first-ever medical respite program for the unhoused Mercy Arkansas Hospitals receive designation Sage Health to Open Third Central Arkansas Location UAMS snags $11.5M after cyberattack CHI St. after cyberattack CHI St.

article thumbnail

Health Provider News – February 10, 2023

Hall Render

Dunleavy proposes extending Medicaid coverage for new mothers ARIZONA Banner Health pays $1.25M penalty over HIPAA failures from 2016 breach Arizona nursing school at risk of losing accreditation St. billion since pandemic U.S. billion since pandemic U.S. billion since pandemic U.S. billion since pandemic U.S.

article thumbnail

Health Provider News

Hall Render

Here’s why.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Executive Health Resources, Inc. , Executive Health Resources, Inc. , United States Department of Health and Human Services , 58 F.4th In 2023, these include United States ex rel. Polansky v. UnitedHealthcare, Inc. , 3d 239 (Cal. Croda Inc. , 3d 191 (Del. C-8 Personal Injury Litigation , 87 F.4th

FDA 105